HOME >> BIOLOGY >> NEWS
NHLBI study finds improved heart failure survival

Survival after a heart failure diagnosis has greatly improved over the past 50 years, according to a study from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health. The study, which analyzed data from the NHLBI's landmark Framingham Heart Study (FHS), found that the risk of dying after being diagnosed with heart failure had dropped by about a third in men and women during that period.

The study, which appears in the October 31, 2002, issue of The New England Journal of Medicine, also found that new cases of heart failure had dropped by about a third for women during the same period. However, the number of new cases for men remained unchanged.

"These findings offer good news about a highly lethal disease," said NHLBI Director Dr. Claude Lenfant. "However, heart failure still affects far too many Americans and more than half of those who develop it die within 5 years of diagnosis.

"Prevention remains the best defense against heart failure. Americans can greatly reduce their chances of developing it by taking steps to prevent or control high blood pressure, heart disease, and other conditions that can lead to heart failure."

Heart failure occurs when the heart loses its ability to pump enough blood through the body. It often develops slowly, over many years. About 4.8 million Americans have heart failure, with about 550,000 new cases being diagnosed each year. Heart failure contributes to about 287,000 deaths a year.

In the new study, researchers, led by FHS Director Dr. Daniel Levy, analyzed data on 10,317 FHS participants drawn from the original enrollees and the offspring generation, including their spouses. The study had equal numbers of men and women.

The original participants, who began enrolling in FHS in 1948, were evaluated every 2 years; the offspring generation, which began enrolling in 1971, was evaluated in 1979 and every 4 years after that. The evalu
'"/>

Contact: NHLBI Communications Office
301-496-4236
NIH/National Heart, Lung, and Blood Institute
30-Oct-2002


Page: 1 2 3

Related biology news :

1. NHLBI awards $68 million to fund clinical centers in pediatric heart disease
2. NHLBI launches innovative proteomics centers
3. NHLBI study finds DASH diet and reduced sodium lowers blood pressure for all
4. NHLBI supported study finds inhaled steroids accelerate bone loss in women with asthma -- treatment still recommended for persistent asthma
5. NHLBI unveils new resources to help consumers control their blood pressure
6. NHLBI study shows reduced fat intake to lower cholesterol is safe and beneficial for children
7. Reducing sodium leads to substantial drop in blood pressure, finds NHLBI study
8. NHLBI launches genomic applications initiative -- $37 million awarded in initial effort
9. Two NHLBI studies confirm finding of gene in primary pulmonary hypertension
10. NHLBI study shows large blood pressure benefit from reduced dietary sodium
11. Student science contest participation influences study, career choices, alumni say

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: